[{"Assets_0_Q2_USD":11428700000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.21,"EarningsPerShareDiluted_2_Q2_USD":0.54,"EarningsPerShareDiluted_1_Q2_USD":0.07,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":136000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":136000000.0,"EarningsPerShareBasic_2_Q2_USD":0.54,"EarningsPerShareBasic_1_Q2_USD":0.07,"StockholdersEquityConverted_0_Q2_USD":5726400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":136300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":136500000.0,"StockholdersEquity_0_Q2_USD":5726200000.0,"NetIncomeLossConverted_1_Q2_USD":9000000.0,"NetIncomeLossConverted_2_Q2_USD":72900000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":158300000.0,"CommonStockSharesConverted_0_Q2_shares":136000000.0,"RevenuesConverted_1_Q2_USD":1149000000.0,"RevenuesConverted_2_Q2_USD":2323500000.0,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20190808"}]